On this week’s Tech Nation, Moira speaks with former UC Irvine professor, Dr. Hans Keirstead, the chairman and CEO of Aivita Biomedical. They’re talking about adult stem cells, in your body right now, and work in treating spinal cord injury, and in ovarian cancer, melanoma, the skin cancer, glioblastoma … and even in a vaccine for COVID-19, this one designed to be affordable for everyone, everywhere.

On this week’s Tech Nation, we’re talking about “Good Medicine … Health, Ethics and Innovation”. It’s a Collaboration Between Bioethics International and Scientific American. We’ll hear from Jennifer Miller, a professor at the Yale University School of Medicine, and Jeremy Abbate, the publisher of Scientific American. Then Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about existing drugs being repurposed in the fight against COVID. And what gets us to stick with all that personal health technology we need? Rick Anderson is the President and General Manager for North America at Dario Health.

On this week’s Tech Nation, spurred by the re-opening of expeditions to the summit of Mount Everest, after a one-year closure due to COVID-19, a 1993 interview with Sir Edmund Hillary, who with his climbing partner, Sherpa Tenzing Norgay, was the first to reach the summit. Then Dr. Gene Kinney, the President & CEO of Prothena Biosciences, a new drug in clinical trials for Parkinson’s. How Parkinson’s unfolds in the brain, the idea behind how this drug, and the hope of slowing, if not stopping, disease progress.

On this week’s Tech Nation, Moira speaks with Walter Isaacson about “The Code Breaker: Jennifer Doudna (“DOWDna”), Gene Editing, and the Future of the Human Race.” Then Tech Nation Health Chief Correspondent Dr. Daniel Kraft takes us through the slate of winners of the $6 Million Rapid COVID Screening Xprize.

On this week’s Tech Nation, learning to draw on the radio! Dan Roam, the founder of The Napkin Academy, invites us to make simple drawings showing what the COVID-19 pandemic looks like to each of us. They’ll also talk about his writer’s workshop and how he’s writing his upcoming book– “The Pop-Up Pitch” – he’s inviting all nonfiction writers to write their books along with him.

On this week’s Tech Nation, Ohio State University professor Angus Fletcher connects neuroscience and literature, and why stories can be so compelling – from Greek tragedy to modern times. His book is “Wonderworks … the 25 Most Powerful Inventions in the History of Literature”. Then a ten-minute primer with David Peterson, best known for creating alien languages for HBO’s Game of Thrones, Netflix's The Witcher, and Marvel's Doctor Strange

On this week’s Tech Nation, Dr. Jonathan Javitt from NeuroRX Pharma talks about a scientific discovery which lingered for nearly two decades in some 70 boxes in deep storage – it’s now being tested as a treatment for COVID-19. Then Rick Carreon, the CEO of ImpediMed, tells us about a technology developed in the 1990’s for research purposes. Today it’s approved for the early detection of lymphedema following breast cancer – and early intervention can stop its progression.

On this week’s Tech Nation, Wharton Marketing Professor, Jonah Berger, follow his earlier books, “Contagious” and “Invisible Influence”. His latest is “The Catalyst – How To Change Anyone’s Mind”. Then on BioTech Nation, using viruses to our benefit. That’s the idea from Aspa Therapeutics. Dr. Eric David described Aspa’s approach to deliver essential treatment for the rare genetic condition of Canavan’s Disease.

On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.

On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.